Back to Point72 Asset Management, L.P. Point72 Asset Management, L.P.

MBX

7 quarters

Position history for Point72 Asset Management, L.P.Point72 Asset Management, L.P.'s holdings in MBX Biosciences, Inc.

No. Point72 Asset Management exited its MBX (MBX Biosciences) position in Q1 2026. Its Q4 2025 13F listed 680,609 shares worth $21.5M. Point72 Asset Management already held MBX in its Q3 2024 13F, the earliest on record, and held it in 5 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$405,288

Total Shares Change

-15,600

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$29.85
0
2025-Q4
Increased
680,609
+8.4%
$21.5M0.0%$31.54
31
2025-Q3
Decreased
627,667
-35.5%
$11M0.0%$17.50
0
2025-Q2
Increased
973,787
+781.4%
$11.1M0.0%$11.41
45
2025-Q1
New
110,482
-
$815,3570.0%$7.38
34
2024-Q4
Exited
0
-100.0%
$00.0%$18.43
0
2024-Q3
New
15,600
-
$405,2880.0%$23.95
33

Other major holders of MBX: FMR LLC, Wellington Management Group LLP, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used